Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.440
+0.030 (1.24%)
At close: Jan 8, 2026, 4:00 PM EST
2.450
+0.010 (0.41%)
After-hours: Jan 8, 2026, 7:42 PM EST
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $93.85 million as of January 8, 2026. Its market cap has increased by 125.35% in one year.
Market Cap
93.85M
Enterprise Value
83.34M
1-Year Change
125.35%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $93.85M, a decrease of -24.71%. That is a compound annual growth rate of -5.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 92.69M | -25.16% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 950.93B |
| Johnson & Johnson | 494.03B |
| AbbVie | 395.81B |
| UnitedHealth Group | 317.88B |
| AstraZeneca | 293.89B |
| Merck & Co. | 271.31B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |